- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07937397
Acute Effects of Green Tea Intake on Countermovement Jump and Cognitive Performance in Taekwondo Athletes (green-tea)
Acute Effects of Green Tea Intake on Countermovement Jump and Cognitive Performance in Taekwondo Athletes: A Randomized, Placebo-Controlled Crossover Trial
This study aims to investigate the acute effects of green tea intake on countermovement jump performance and cognitive performance in male Taekwondo athletes. A randomized, placebo-controlled, three-condition crossover design will be used. Each participant will complete control, placebo, and green tea conditions in a randomized and counterbalanced order, with a washout period of at least 72 hours between sessions. CMJ performance will be assessed as the primary outcome, followed by the Stroop test as the secondary outcome.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Following a familiarization session, participants will complete three experimental sessions. At the beginning of each session, body weight will be measured. Participants will then receive the assigned condition and wait for 60 minutes. After a standardized warm-up, CMJ performance will be assessed using the My Jump Lab application. Following a 5-minute standardized rest period, cognitive performance will be evaluated using the Stroop test. The order of experimental conditions will be randomized and counterbalanced among participants.
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
Healthy male Taekwondo athletes aged 18-25 years.
At least 3 years of licensed Taekwondo experience.
Regular Taekwondo training at least 3 days per week during the previous 6 months.
Willingness to participate voluntarily and provide written informed consent.
Exclusion Criteria:
Presence of any chronic disease.
Cardiovascular, metabolic, or neurological disorders.
Lower-extremity injury or surgery within the previous 6 months.
Regular medication use.
Known sensitivity to caffeine or green tea.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Grundläggande vetenskap
- Tilldelning: Randomiserad
- Interventionsmodell: Crossover tilldelning
- Maskning: Dubbel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Control
Participants will complete the control condition without receiving green tea or placebo. |
Participants will not receive green tea extract or placebo during the control condition. They will follow the same experimental procedures and assessment schedule as in the other conditions, including a 60-minute waiting period before the standardized warm-up and performance assessments. |
|
Placebo-jämförare: Placebo
Participants will receive a placebo preparation |
Participants will receive a placebo orally 60 minutes before the performance assessments. |
|
Experimentell: Green Tea
Participants will receive a standardized green tea extract preparation. |
Participants will receive green tea extract orally 60 minutes before the performance assessments. The intervention will be administered according to the study protocol. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Countermovement Jump (CMJ) Performance
Tidsram: Immediately after the 5-minute rest period following the CMJ assessment.
|
Cognitive performance will be assessed using the Stroop test. Performance will be evaluated based on reaction time and accuracy. |
Immediately after the 5-minute rest period following the CMJ assessment.
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Cognitive Performance Assessed by the Stroop Test
Tidsram: Immediately after the 5-minute rest period following the CMJ assessment.
|
Cognitive performance will be assessed using the Stroop test. Reaction time and accuracy (number of correct responses and errors) will be recorded. |
Immediately after the 5-minute rest period following the CMJ assessment.
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- INU-ARCH-2026-25
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .